Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9076
-0.0379 (-4.01%)
At close: Jul 24, 2026, 4:00 PM EDT
0.9175
+0.0099 (1.09%)
After-hours: Jul 24, 2026, 7:57 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $173.14 million as of July 24, 2026. Its market cap has increased by 42.88% in one year.
Market Cap
173.14M
Enterprise Value
170.58M
1-Year Change
42.88%
Ranking
Category
Stock Price
$0.91
ChartMarket Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $173.14M, a decrease of -66.32%. That is a compound annual growth rate of -20.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 173.14M | 21.17% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 253.16M |
| RxSight | 217.54M |
| InfuSystem Holdings | 181.64M |
| Quanterix | 181.12M |
| Quantum-Si incorporated | 178.65M |
| Inogen | 174.09M |
| Apyx Medical | 170.01M |
| Owlet | 156.90M |